Position in ILMN
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$293,479
-$16,579 QoQ
Shares Held
2,381
+0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026JOURNEY STRATEGIC WEALTH LLC holds $4,914,663 across 7 Diagnostics & Research names. ILMN ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,807 | $1,871,252 | |
| 2 | DHR |
Danaher Corp /De/
|
7,674 | $1,454,986 | |
| 3 | NTRA |
Natera, Inc.
|
2,134 | $426,774 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
823 | $395,195 | |
| 5 | ILMN |
Illumina, Inc.
This page
|
2,381 | $293,479 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
445 | $250,036 | |
| 7 | A |
Agilent Technologies, Inc.
|
1,956 | $222,941 |
All Filings in ILMN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $293,479 | 2,381 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $310,058 | 2,364 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $200,574 | 2,112 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $288,371 | 2,158 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $242,951 | 1,863 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||